1887

Abstract

SUMMARY

Monolayers of primary rabbit kidney cells infected with HSV type 1 bound lymphoblastoid (Raji) cells, to which the third component (C3) of the complement system had been attached (Raji-C3). This induction of cell contact did not occur on non-infected monolayers and was dependent on C3. The interaction could be suppressed by the presence of protease inhibitors (1 m-TLCK or-PMSF). The results are interpreted as indicating expression of protease activity on the surface of HSV-infected cells. This protease is characterized by its potential to activate C3 and its inhibition by TLCK.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-45-1-241
1979-10-01
2022-06-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/45/1/JV0450010241.html?itemId=/content/journal/jgv/10.1099/0022-1317-45-1-241&mimeType=html&fmt=ahah

References

  1. Bokisch V. A., Dierich M. P., Müler-Eberhard H. J. 1975; Third component of complement (C3): structural properties in relation to functions. Proceedings of the National Academy of Sciences of the United States of America 72:1989–1993
    [Google Scholar]
  2. Capel P. J. A., Groeneboer O., Grosveld G., Pondman K. W. 1977; A lectin like activity of activated C3. Pathologia et Biologia 25:394
    [Google Scholar]
  3. Clauss J., Falke D. 1971; Immunadharenz zum Nachweis virus-spezifischer Antigene und Antikorper. III. Untersuchungen iiber die Komplement-Aktivierung an Zelloberflachen. Zeitschrift für Medizinische Mikrobiologie und Immunologie 156:272–283
    [Google Scholar]
  4. Dierich M. P., Landen B. 1977; Complement bridges between cells: analysis of a possible cell-cell interaction mechanism. Journal of Experimental Medicine 146:1484–1499
    [Google Scholar]
  5. Dierich M. P., Schulz T., Yefenof E., Klein G. 1979a; Detection of proteolytic (C3-cleaving) activity on mouse mastocytoma (P815) cells and other mouse cell lines by formation of cell contact with C3-carrying mouse lymphocytes. European Journal of Immunology (in the press)
    [Google Scholar]
  6. Dierich M. P., Schulz T., Yefenof E., Klein G. 1979b; C3-activating proteases on human lymphoblastoid cells superinfected with Epstein-Barr-virus. Cellular Immunology (in the press)
    [Google Scholar]
  7. Flanagan J. F. 1966; Hydrolytic enzymes in KB cells infected with poliovirus and Herpes simplex virus. Journal of Bacteriology 91:789–797
    [Google Scholar]
  8. Hatcher V. B., Oberman M. S., Wertheim M. S., Rhee Y., Tsien G., Burk P. O. 1977; The relationship between surface protease activity and the rate of cell proliferation in normal and transformed cells. Biochemical and Biophysical Research Communications 76:602–608
    [Google Scholar]
  9. Howett M. K., High C. S., Rapp F. 1978; Production of plasminogen activator by cells transformed by herpes viruses. Cancer Research 38:1075–1078
    [Google Scholar]
  10. Ito M., Barron S. 1972; Surface antigen produced by herpes simplex virus (HSV). Journal of Immunology 108:711–712
    [Google Scholar]
  11. Lee L. S., Weinstein B. 1978; Epidermal growth factor, like phorbolesters, induces plasminogen activator in HeLa cells. Nature, London 274:696–697
    [Google Scholar]
  12. Lundblad H. S., Kingdon R. L., Mann K. G. 1976 In Methods in Enzymology vol xlv: pp 173–174 Edited by Colowick S. P., Kaplan N. A. New York: Academic Press;
    [Google Scholar]
  13. Peterknecht W., Bitter-Suermann D., Falke D. 1968; Immunadharenz zum Nachweis virusspezifischer Antikorper und Antigene. II. Immunadharenz-Hamad sorption zum Nachweis zell-und virusspezifischer Antigene auf Kulturzellen. Zeitschrift fiir Medizinische Mikrobiologie und Immunologie 154:234–244
    [Google Scholar]
  14. Reich E. 1974; Secretion of enzymes by neoplastic cells and macrophages. In Proteinase Inhibitors Bayer-Symposium V, pp 621–630 Edited by Fritz H., Tschesche H., Greene L. J., Truscheit E. Berlin, Heidelberg, New York: Springer Verlag;
    [Google Scholar]
  15. Roizman B. 1962; Polykaryocytosis. Cold Spring Harbor Symposia on Quantitative Biology 24:327–342
    [Google Scholar]
  16. Sakuma S., Furukawa T., Plotkin S. A. 1977; The characterization of IgG receptor induced by human cytomegalovirus. Proceedings of the Society for Experimental Biology and Medicine 155:168–172
    [Google Scholar]
  17. Schreiber R. D., Pangburn M. K., Lesavre P. H., Müller-Erfrhard H. J. 1978; Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins. Proceedings of the National Academy of Sciences of the United States of America 75:3948–3952
    [Google Scholar]
  18. Spear P. G., Keller J. M., Roizman B. 1970; Proteins specified by Herpes simplex virus. II. Viral glycoproteins associated with cellular membranes. Journal of Virology 5:123–131
    [Google Scholar]
  19. Tack B. F., Prahl J. 1976; The third component of human complement: purification from plasma and physico-chemical characterization. Biochemistry 15:4513–4519
    [Google Scholar]
  20. Tevethia S. S., Lowry S., Rawls W. E., Melnick J. L., Mcmillan V. 1972; Detection of early cell surface changes in herpes-simplex-virus infected cells by agglutination by Concanavalin A. Journal of General Virology 15:93–97
    [Google Scholar]
  21. Watkins J. F. 1964; Adsorption of sensitized sheep erythrocytes to HeLa cells infected with herpes simplex virus. Nature, London 202:1364–1365
    [Google Scholar]
  22. Westmoreland D., Watkins J. F. 1974; The IgG receptor induced by herpes simplex virus: studies using radioiodinated IgG. Journal of General Virology 24:167–178
    [Google Scholar]
  23. Westmoreland D., Watkins J. F., Rapp F. 1974; Demonstration of a receptor for IgG in Syrian Hamster cells transformed with Herpes simplex virus. Journal of General Virology 25:167–170
    [Google Scholar]
  24. Westmoreland D., Joer S., Rapp F. 1976; The development by cytomegalovirus infected cells of binding affinity for normal human immunoglobulin. Journal of Immunology 116:1566–1570
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-45-1-241
Loading
/content/journal/jgv/10.1099/0022-1317-45-1-241
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error